Journal News

The ‘phospho-dawn’ of circadian clock proteomics

Nivedita Uday Hegdekar
March 9, 2022

As a Ph.D. student at the University of Edinburgh, Johanna Krahmer was interested in researching circadian rhythms, which are key physiological changes that follow a 24-hour cycle. These natural processes respond primarily to light and dark and affect most living things, including animals, plants and microbes. She joined Andrew Millar’s lab, which researched how circadian rhythms are developed and affect plant life from the cell to the ecosystem.

Circadian clock

Most genetic studies in circadian biology research have focused on gene expression levels. However, protein abundance and post-translational modifications tell a larger story about circadian rhythms, making it essential to study these changes as well.

“Many transcription factor proteins that genetically control circadian rhythms also undergo post-translational modifications,” Krahmer said. “One such modification —protein phosphorylation — is involved in the circadian clock mechanism not only in plants but also in fungi and eukaryotes.”

Krahmer was interested in investigating circadian rhythms in protein abundance and phosphorylation PTM changes in a normally functioning circadian clock system. She used mass spectrometry to generate global proteomics and phosphoproteomics datasets on circadian time courses in the Arabidopsis thaliana plant.

“We found that about 0.4% of global proteins but a much larger percentage of the quantified phosphorylation sites were altered due to the circadian clock,” Krahmer said. “Furthermore, approximately half of these rhythmic phosphosites were most phosphorylated at dawn, a pattern we termed the ‘phospho-dawn.’”

Krahmer discovered that many phosphorylated proteins are those involved in circadian clock regulation, such as MAPK, CK2 and GSK. She also showed that the genetic clock circuit is required for most rhythmic protein phosphorylation.

Using an Arabidopsis thaliana plant line with a disabled clock gene circuit, Krahmer found that most of the most circadian protein phosphorylation was lacking. However, a few phosphorylation sites that fluctuated despite the disabled circadian clock still tended to peak in abundance close to subjective dawn.

“This may suggest that the canonical circadian mechanism is necessary for most but perhaps not all protein phosphorylation rhythms,” Krahmer said.

To exemplify in an experimental approach how circadian phosphorylation of a protein can be linked to its function, she analyzed the effect of a mutation in the phosphorylation site on the activity of the metabolic enzyme F2KP (one of the identified proteins in her data sets). F2KP is one of the regulators of carbon partitioning into starch and sucrose. It is necessary to maintain normal growth in fluctuating light conditions. Krahmer showed that the phosphorylated serine of F2KP has functional relevance in plant metabolism. Her findings recently were published in the journal Molecular and Cellular Proteomics.

Following her Ph.D., Krahmer pursued postdoctoral research in Karen Halliday’s lab at the University of Edinburgh and now works at Christian Fankhauser’s lab at the University of Lausanne. Her research interests have expanded to the role of metabolism in photobiology.

“If there is one major takeaway message from my Ph.D. work,” she said, “it’s that that protein changes and PTMs should be an important part of circadian biology research.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nivedita Uday Hegdekar

Nivedita Uday Hegdekar is a recent Ph.D. graduate in biochemistry and molecular biology from the University of Maryland, Baltimore.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Building the blueprint to block HIV
Profile

Building the blueprint to block HIV

Dec. 11, 2025

Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.

Gut microbes hijack cancer pathway in high-fat diets
Journal News

Gut microbes hijack cancer pathway in high-fat diets

Dec. 10, 2025

Researchers at the Feinstein Institutes for Medical Research found that a high-fat diet increases ammonia-producing bacteria in the gut microbiome of mice, which in turn disrupts TGF-β signaling and promotes colorectal cancer.

Mapping fentanyl’s cellular footprint
Journal News

Mapping fentanyl’s cellular footprint

Dec. 4, 2025

Using a new imaging method, researchers at State University of New York at Buffalo traced fentanyl’s effects inside brain immune cells, revealing how the drug alters lipid droplets, pointing to new paths for addiction diagnostics.

Designing life’s building blocks with AI
Profile

Designing life’s building blocks with AI

Dec. 2, 2025

Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Cholesterol as a novel biomarker for Fragile X syndrome
Journal News

Cholesterol as a novel biomarker for Fragile X syndrome

Nov. 28, 2025

Researchers in Quebec identified lower levels of a brain cholesterol metabolite, 24-hydroxycholesterol, in patients with fragile X syndrome, a finding that could provide a simple blood-based biomarker for understanding and managing the condition.

How lipid metabolism shapes sperm development
Journal News

How lipid metabolism shapes sperm development

Nov. 26, 2025

Researchers at Hokkaido University identify the enzyme behind a key lipid in sperm development. The findings reveal how seminolipids shape sperm formation and may inform future diagnostics and treatments for male infertility.